- Eli Lilly's Ladies' Drug Campaign: Kind of Strange TV Ad?

- Reporters Barred from Ariad, Celgene, Cougar Roundtable?
- Amgen CEO To Shareholders: I Feel Your Pain, Too

- Amgen's Visit From The "Tooth Fairy" (By Way Of Root Canal?)

- Merck's Layoffs Show Pain Of Lower Drug Sales,Too Many Reps
- Pfizer "Re-Lighting" Chantix Ad Campaign For Smokers?
- Fixing Pfizer And Your Emails
- Former Merck CEO Prodding Industry On Drug Pricing
- Merck "Adapts" To Tredaptive Setback

- Regulatory "Risky Business" for Pharma & Biotech
- Eli Lilly's Ladies' Drug Campaign: Kind of Strange TV Ad?
- Your First Move For Tuesday May 13th

- Web Extra: A Taste for Chips

- Emerging Money: China
- Pops & Drops: Alcoa, Blockbuster...

- Future Trade: Robotic Surgery

- Chartology: Commodity Trade 2.0

- Why Wal-Mart Is Working

- Stocks Rebound From Last Week's Drop

- Lightning Round OT: Raytheon, Apache and More
- Mad Mail: Botox Shakedown Party?
- Your First Move For Tuesday May 13th
- Wal-Mart Shares Fall on Weak Earnings Forecast
- H-P Confirms Deal to Buy EDS for $13.9 Billion
- Fed's Pianalto Says Inflation 'A Key Risk'
- Wal-Mart Profit Rises as Shoppers Hunt for Bargains
- UK Inflation Jumps, Curbing Rate Cut Expectations
- Airbus Hit by New A380 Delivery Delay
- Banks, Oils Drag Markets into the Red
- Staples Raises Hostile Corporate Express Bid
- It's A Sony
- Charting Asia | Sony Chart

![]() |
CNBC.com |
I'm outside the Four Seasons Hotel in Westlake Village, CA, where the get-together takes place this afternoon. Reporters will be allowed inside to take notes, but we can't use any recording equipment--i.e. a TV camera.
Anyway, Steve Silverman who has owned AMGN [AMGN
Loading...
(%)
] shares for about two decades and has gotten "very rich" off the investment, was the self-appointed ringleader of a shareholder protest of sorts.
On message boards, in chat rooms and in the media Mr. Silverman was trying to spearhead a campaign to oust Chairman and CEO Kevin Sharer and the Board of Directors. The 70-year-old retired insurance man admits it was a long shot.
related content |
He's upset over the stock's decline and what he sees as a series of management missteps. Amgen defends Sharer saying the company has grown "dramatically" on his watch.
![]()
Yesterday afternoon Mr. Silverman sent me an email saying he won't be speaking out at the meeting after all. He explains he has a toothache that requires emergency root canal today.
He added that he spoke to Sharer on the phone yesterday for almost 90 minutes and concluded, "He is interesting but definitely has his views and positions on the company. I still would not vote for him."
An Amgen spokesman confirms the phone call took place, but says that it didn't last quite as long.
Questions? Comments?




